DIVA Laboratories, Ltd. (TPEX:4153)

DIVA Laboratories Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	642.57	589.14	536.93	346.37	299.28	323.76
Trading Asset Securities	2.13	-	-	-	-	3.92
Cash & Short-Term Investments	644.7	589.14	536.93	346.37	299.28	327.67
Cash Growth	6.10%	9.72%	55.02%	15.73%	-8.67%	-41.55%
Accounts Receivable	262.2	262.41	203.13	281.89	190.37	188.14
Other Receivables	29.29	23.45	10.08	19.55	13.31	8.2
Receivables	291.48	285.86	213.2	301.44	203.68	196.35
Inventory	191.99	151.42	196.21	319.3	352.32	250.19
Prepaid Expenses	4.21	3.88	4.86	8.42	11.5	11.78
Other Current Assets	1.96	0.75	5.21	0.86	7.8	5.55
Total Current Assets	1,134	1,031	956.41	976.39	874.57	791.53
Property, Plant & Equipment	219.07	222.96	231.46	225.57	227.56	232.92
Long-Term Investments	4.44	5.03	4.61	6.32	30.94	35.45
Goodwill	-	-	-	-	5.18	5.18
Other Intangible Assets	1.25	1.71	0.74	1.31	4.41	6.91
Long-Term Deferred Tax Assets	43.65	40.76	47.33	38.27	36.08	35.52
Other Long-Term Assets	4.18	3.92	3.19	3.94	2.94	5.71
Total Assets	1,407	1,305	1,244	1,252	1,182	1,113
Accounts Payable	72.22	70.69	61.07	85.15	103.88	46.41
Accrued Expenses	-	74.97	65.11	67.2	45.6	35.28
Current Portion of Leases	2.57	2.47	2.53	0.13	0.13	0.13
Current Income Taxes Payable	29.72	23.32	22.02	24.35	5.75	8.03
Current Unearned Revenue	6.43	6.51	9.11	8.81	6.2	5.6
Other Current Liabilities	307.75	68.95	43.47	48.95	30.72	27.28
Total Current Liabilities	418.68	246.92	203.31	234.59	192.27	122.72
Long-Term Leases	1.61	2.5	4.97	0.15	0.28	0.41
Long-Term Deferred Tax Liabilities	0.72	0.43	0.87	-	0.02	0.3
Other Long-Term Liabilities	1.16	0.1	1.59	-	-	-
Total Liabilities	422.17	249.94	210.93	235.62	195.27	124.34
Common Stock	586.68	600.91	600.91	617.59	617.59	617.59
Additional Paid-In Capital	347.14	382.33	393.58	400	400	400
Retained Earnings	60.83	124.06	92.02	107.76	78.75	73.95
Treasury Stock	-	-45.99	-45.99	-99.91	-99.91	-99.91
Comprehensive Income & Other	-9.89	-5.8	-7.72	-9.26	-10	-2.74
Total Common Equity	984.77	1,056	1,033	1,016	986.42	988.89
Shareholders' Equity	984.77	1,056	1,033	1,016	986.42	988.89
Total Liabilities & Equity	1,407	1,305	1,244	1,252	1,182	1,113
Total Debt	4.18	4.97	7.51	0.28	0.41	0.54
Net Cash (Debt)	640.52	584.17	529.42	346.08	298.86	327.13
Net Cash Growth	6.50%	10.34%	52.98%	15.80%	-8.64%	-41.65%
Net Cash Per Share	10.87	9.91	8.99	5.88	5.08	4.91
Filing Date Shares Outstanding	58.63	58.67	58.67	58.67	58.67	58.67
Total Common Shares Outstanding	58.63	58.67	58.67	58.67	58.67	58.67
Working Capital	715.66	784.13	753.1	741.8	682.3	668.81
Book Value Per Share	16.80	17.99	17.60	17.32	16.81	16.86
Tangible Book Value	983.51	1,054	1,032	1,015	976.83	976.8
Tangible Book Value Per Share	16.78	17.96	17.59	17.30	16.65	16.65
Land	-	154.92	154.92	154.92	154.92	154.92
Buildings	-	85.42	85.42	85.42	85.42	85.42
Machinery	-	91.36	90.79	86.84	84.46	83.14

Source: S&P Global Market Intelligence. Standard template. Financial Sources.